Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
SOUTH SAN FRANCISCO, Calif. and LEUVEN, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical...
SOUTH SAN FRANCISCO, Calif. and LEUVEN, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical...
Publication Explores the Beneficial Effects of Apabetalone on the Immune Cells of Diabetic Patients Event Reminder: Multiple Presentations on Apabetalone...
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation...
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
Company Ended the Quarter With Cash of Approximately $444 Million NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Immunovant, Inc....
Secure HIPAA compliant technology for at-risk chronic care patients REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc....
WAKIX®(pitolisant) Total Revenue of $45.6 Million for Third Quarter of 2020 Differentiated Product Profile Aligns with Unmet Medical Need On...
ATLANTA, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development...
IJSS-published peer-reviewed studies demonstrate the device’s respect for neural anatomy and conformability to bony endplates through Adaptive Geometry™ PALM BEACH...
PetVivo Holdings, Inc. The treatment of osteoarthritis in canines through the administration of PetVivo’s proprietary medical device, KUSH®. MINNEAPOLIS, Nov....
The Contract Spans Neil Medical Group’s Network of Long-Term Care & Assisted Living Facilities Across the Southeastern United States MOORESTOWN,...
DENVER, CO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”),...
WOBURN, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today...
BASKING RIDGE, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that...
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to...
BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel...
Conference Call Today at 4:30 p.m. Eastern Time SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE),...
Robust Immune Response and Significantly Reduce Viral Load SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc.,...
LOS ANGELES, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTC Pink: TONJ) ( “Company”)...